Coronavirus' Drug mix 'Could Cause liver and Kidney Failure
Recently, this picture named "Novel coronavirus taking medicine Sequence map" has been widely circulated on the Internet and in the circle of friends. From the early, middle, late and even prevention stage of common drugs, it has been collected and praised by the major netizens at the present time when the novel coronavirus is normalized. More people for the distribution of drugs summed up the drug law: "cold medicine is the boss."
But is cold medicine really a god? Is the medication in this picture really so reliable? Are there no risks associated with various combinations of Chinese and Western medicines? Maybe not.
Chinese and Western medicine mix, careful liver and kidney failure risk
Since the lockdown has been lifted across the country, the government and enterprises have significantly reduced their requirements for travel and work (removing the location code and no longer checking nucleic acid test reports in some areas). The main reason may be that the mild symptoms caused by COVID-19, the social and economic benefits and the convenience of the people are taken into consideration.
However, there is no denying that since the resumption of work, the proportion of colleagues and friends around me who have changed from Yin to Yang has also increased significantly. At least many colleagues around me have taken time off after being diagnosed with the disease. It is in this atmosphere that people who have never stocked or prepared medicine before unconsciously start to buy medicine. Naturally, various drug preparation guides similar to the one in the above picture are also emerging one after another. Among the drugs that have been snapped up, the largest proportion is naturally cold medicine, which is known as the "god of anti-epidemic medicine".
But what we don't know is that many common cold medicines are not pure Chinese medicine. Many cold medicines also contain antipyretic and analgesic ingredients. In some aspects, the idea that Chinese and Western medicines work and traditional Chinese medicines break the root is actually wrong from the beginning. It can even cause acute liver and kidney failure.
Take the author's illness as an example, after symptom aggravation, frequent headache, diarrhea, high fever, on one day to eat Gankang, ibuprofen, cold Ling and even flower Qingwen four drugs, in that extremely uncomfortable situation, although the ingredients between drugs have scruple, but it has been difficult to carefully review the detailed ingredients, some just hope to eat quickly better. Fortunately, there were no major problems after that, but I still feel afraid now.
The existence of drugs is reasonable, the cold medicine as the first drug in the daily treatment of cold, the core purpose of adding acetaminophen is to make western medicine help Chinese patent medicine quickly effective, its itself has taken into account the combination of traditional Chinese and Western medicine, finally patients in the process of buying medicine, taking medicine, Chinese and Western medicine mix is actually a little bit of the meaning of icing on the lily. In addition to the serious situation of repeated drug use in cold medicine, hypoglycemic drugs, antihypertensive drugs and digestive tract drugs also face the same problem, and the superimposed effect of repeated drug use has become a problem that cannot be ignored in "Chinese and Western medicine compound preparations".
In the face of today's novel coronavirus treatment, remember not to take a variety of cold medicines together, do not take cold medicines containing acetaminophen, but also take antipyretic medicine!
Are in tun cold medicine, how does digestive tract symptom do?
From the "medication chart" at the beginning of the article, people in the field of pharmacy and medicine know that it may only represent the personal advice of past patients, because according to official data, respiratory symptoms are indeed most of the ten common symptoms of COVID-19 patients, but not all of them, and almost all the drugs mentioned in the chart are targeted at upper respiratory infections. However, there is no mention of digestive symptoms such as diarrhea, which means that nature has no authority over the comprehensive treatment.
Taking the author's personal experience as an example, the author took a lot of antipyretic and analgesic drugs and cold drugs, the symptoms of high fever and respiratory tract have almost completely disappeared, but the symptoms of diarrhea, fatigue and soreness have already existed. Unfortunately, the author did not consider the symptoms of digestive tract when preparing the medicine, so now he can only continue to resist hard at home.
summarize
In fact, the repeated use of cold medicine compound preparations and Western medicines has existed for a long time in history, as reflected by the COVID-19 pandemic. The fact that some Chinese patent medicines contain western ingredients is also an inevitable result of fixed historical stage.
With the development of The Times and the discovery of side effects of Chinese and Western medicine compound preparations, more and more medical experts have raised doubts about "Chinese and Western medicine compound preparations". They believe that this kind of compound preparations do not conform to modern medical theories, nor traditional Chinese medicine theories. There are many unknown problems in preparation technology and quality control. However, there is no research data to confirm the difference in efficacy between the drug and chemical drug alone, and the study of drug interaction is also a blank.
Therefore, after the introduction of the Drug Administration Law in 1985, China stopped the approval of new Chinese and Western drug compound preparations through continuous improvement and perfection of the registration and approval, and the situation is expected to further improve in the future.
Looking for chemical products? Let suppliers reach out to you!
2026-06-03
-
Life Science Ingredients Industry Overview
This issue offers a deep exploration of the evolving pharmaceutical and nutrition landscape, combining data, analysis, and insight to reveal key industry shifts and emerging directions. Support online permanent download.Published in: Nov. 2025
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Reducing to Refocus: Novo Nordisk’s 9,000-Job Cut and the Strategic Realignment in Pharma
-
China Registers First PHA Microsphere Medical Filing Empowering Over 3 Major Application Areas
-
Eli Lilly Makes 1 Billion Dollar Bet on Opioid-Free Pain Relief with Bold SiteOne Acquisition
-
Johnson and Johnson Hit with 147 Million Dollar Fine in Device Antitrust Case Shaking Medical Industry
-
20 Percent Sales Drop in China Triggers Merck Leadership Shakeup as 36 Launches Fail to Halt Slide
-
7 Pharma Giants See Q1 Sales Drop Pfizer Slips to Fourth as Cancer Race Heats Up
-
FDA Fee Updates Raise the Cost of Entering the U.S. Generic Drug Chain
-
API Supplier Audits Move to the Center of Pharma Supply Resilience
-
FDA Clears Sanofi’s Wayrilz (rilzabrutinib) for Adult ITP; U.S. Launch in September
-
AstraZeneca Targets Year-End Filing for Novel Hypertension Drug Baxdrostat
Recommend Reading
-
Aficamten Beats Metoprolol in Obstructive HCM, Strengthening Case Ahead of FDA Decision
-
Over 70% of Patients Find Relief in Bayer’s New Breakthrough Drug for Breast Cancer Menopause Symptoms
-
Eisai Pharma Unveils Bold Plan: $100 Million Global Center Set to Transform Visakhapatnam Now
-
Novo Nordisk Submits Higher Dose of Wegovy One in Three Achieves Over 25 Percent Weight Loss
-
Pharma Tariff Risk Pushes Global Drugmakers to Rebuild U.S. Supply Chains
-
South Korea’s Petrochemical Exports Plunge 18.7% in August Despite Semiconductor and Auto Boom
-
ConocoPhillips to Cut Up to 25% of Workforce as Oil Price Slump Bites
-
Europe’s Recycling Industry in Crisis: Cheap Imports and Red Tape Push Plastic Recyclers to the Brink
-
Europe’s Chemicals Industry Stalls Again as Cefic Cuts 2025 Outlook
-
Europe’s Petrochemical Industry Slashes Cracker Capacity in Historic Retrenchment